For assistance, call
1-855-727-6274

For assistance, call
1-855-727-6274

Otsuka_Patient_Assistance_Foundation_KO_Logo Otsuka_Patient_Assistance_Foundation_KO_Logo ABILIFY MAINTENA® (aripiprazole) JYNARQUE® (tolvaptan) REXULTI® (brexpiprazole) SAMSCA® (tolvaptan) $ R x

Making a real difference
in people's lives

smiling man

The Otsuka Patient Assistance Foundation, Inc. (OPAF) is a nonprofit organization that provides eligible patients with prescribed Otsuka medication free of cost.

For assistance, please contact a Dedicated Patient Case Coordinator at 1-855-727-6274.

U.S. Healthcare Professionals Icon

U.S. Healthcare Professionals

If your patient qualifies for assistance from OPAF, the next step is for you to submit an application on their behalf.

APPLY ONLINE
Patients Icon

Patients

See if you may qualify for no-cost medication assistance.

CHECK ELIGIBILITY

For U.S. Healthcare Professionals

When you sign up for the OPAF Care Connect Portal, you can:

  • Submit OPAF applications online and receive eligibility determination within 48 hours
  • Download OPAF applications and access patient documentation
  • Prescription order submission and tracking for:
    • ABILIFY MAINTENA® (aripiprazole)
    • JYNARQUE® (tolvaptan)
    • REXULTI® (brexpiprazole)
    • SAMSCA® (tolvaptan)

Register now

female Healthcare Professional using a computer

COVID-19 UPDATE

During this extraordinary time, Otsuka Patient Assistance Foundation, Inc. (OPAF) continues to assist patients that have been prescribed an Otsuka medication. Our foundation is open during our standard business hours of Monday-Friday 8am-8pm EDT.

If you are facing a hardship because of the COVID-19 crisis such as:

  • Changes to your employment status such as losing your job or being temporarily furloughed;
  • Changes in your insurance or medication costs;

Please contact OPAF immediately at 1-855-727-6274 to discuss potential assistance.

We are continuing our goal of helping patients that are facing difficulty accessing their prescribed Otsuka medication.

April 2020PAUS20EUC0002

COVID-19 UPDATE

During this extraordinary time, Otsuka Patient Assistance Foundation, Inc. (OPAF) continues to assist patients that have been prescribed an Otsuka medication. Our foundation is open during our standard business hours of Monday-Friday 8am-8pm EDT.

If you are facing a hardship because of the COVID-19 crisis such as:

  • Changes to your employment status such as losing your job or being temporarily furloughed;
  • Changes in your insurance or medication costs;

Please contact OPAF immediately at 1-855-727-6274 to discuss potential assistance.

We are continuing our goal of helping patients that are facing difficulty accessing their prescribed Otsuka medication.

April 2020PAUS20EUC0002

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:

  • Federal Income Tax Return (1040, etc.)
  • W-2 from previous tax year
  • 1099-MISC form
  • Two most recent paystubs
  • Social Security award letter
  • Disability income information
  • Unemployment benefits letter
  • Letter from employer on company letterhead

The application must also include an acceptable proof of residency. Acceptable documentation includes one of the following:

  • Social Security number
  • State driver’s license
  • US birth certificate
  • US passport
  • Foreign passport with US visa
  • I-94 form with photograph
  • US military ID
  • US certificate of naturalization or citizenship

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.